1. P1044: REAL-WORLD RUXOLITINIB TREATMENT PATTERN IN MYELOFIBROSIS PATIENTS WITH THROMBOCYTOPENIA. (23rd June 2022) Authors: Mei, J.; Wang, Y.; Kabir, S.; Ichikawa, N.; Iino, S.; Lebedinsky, C. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 934 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The AXL inhibitor, TP-0903, reverses EMT and shows activity in non-small cell lung cancer preclinical models. (October 2022) Authors: Joe, R.; Matsumura, Y.; Siddiqui, A.; Foulks, J.; Beg, M.; Thompson, J.; Yamamoto, N.; Spira, A.; Sarantopoulos, J.; Melear, J.; Lou, Y.; Lebedinsky, C.; Li, J.; Watanabe, A.; Warner, S. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗